← Open Payments lookup

LINDA MUNSON: Open Payments

NPI 1477542561 · VALPARAISO, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,391 in 66 payments from 13 companies in 2025. Trend: 2023 $1,021 · 2024 $894 · 2025 $1,391

Food & beverage: $1,391
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.11$253
Otsuka America Pharmaceutical, Inc.10$192
Lundbeck LLC12$181
Teva Pharmaceuticals USA, Inc.6$160
Vanda Pharmaceuticals Inc.4$155
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$132
Orexo US, Inc.5$106
Axsome Therapeutics, Inc.4$65
Alkermes, Inc.3$63
E.R. Squibb & Sons, L.L.C.2$35

Products named: INGREZZA, ABILIFY MAINTENA, REXULTI, FANAPT, CAPLYTA, AUSTEDO XR, Zubsolv, Auvelity.

Industry payments across IN — which companies pay providers there.